Literature DB >> 8194469

Effects of transforming growth factor-beta on parathyroid hormone-related protein production and ribonucleic acid expression by a squamous carcinoma cell line in vitro.

J I Merryman1, J W DeWille, J R Werkmeister, C C Capen, T J Rosol.   

Abstract

The effects of human recombinant transforming growth factor (TGF)-beta 1 were determined on PTH-related protein (PTHrP) production and messenger RNA (mRNA) expression by a canine squamous carcinoma cell line (SCC 2/88) in vitro. TGF-beta increased PTHrP production in a dose- and time-dependent manner (P < 0.05) as measured by RIA, and the effects of TGF-beta treatment persisted up to 72 h after removal. TGF-beta increased PTHrP production by SCC 2/88 cells until cellular confluence, at which time there was no longer a significant increase compared to control. Actinomycin D inhibited the TGF-beta-mediated increase in PTHrP production, suggesting that TGF-beta acted in part by increasing gene transcription. SCC 2/88 cells also produced active TGF-beta as measured by a [3H]thymidine incorporation assay in mink lung epithelial cells. Exposure of SCC 2/88 cells to a neutralizing anti-TGF-beta monoclonal antibody decreased (up to 50%, P < 0.01) basal PTHrP production. TGF-beta increased PTHrP mRNA expression in a dose- and time-dependent manner as evaluated by northern blot analysis. Postconfluent SCC 2/88 cells expressed little mRNA for PTHrP, and there was only a minimal increase in PTHrP mRNA expression in postconfluent TGF-beta-treated cells. These results indicate that TGF-beta increased PTHrP production and mRNA expression in malignant keratinocytes and suggest that TGF-beta may be an important factor in the pathogenesis of humoral hypercalcemia of malignancy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8194469     DOI: 10.1210/endo.134.6.8194469

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  13 in total

1.  Guanosine nucleotides inhibit different syndromes of PTHrP excess caused by human cancers in vivo.

Authors:  Wolfgang E Gallwitz; Theresa A Guise; Gregory R Mundy
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

2.  Parathyroid hormone-related peptide (PTHrP)-dependent and -independent effects of transforming growth factor beta (TGF-beta) on endochondral bone formation.

Authors:  R Serra; A Karaplis; P Sohn
Journal:  J Cell Biol       Date:  1999-05-17       Impact factor: 10.539

3.  Humoral hypercalcemia of malignancy: severe combined immunodeficient/beige mouse model of adult T-cell lymphoma independent of human T-cell lymphotropic virus type-1 tax expression.

Authors:  V Richard; M D Lairmore; P L Green; G Feuer; R S Erbe; B Albrecht; C D'Souza; E T Keller; J Dai; T J Rosol
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

4.  Parathyroid hormone and transforming growth factor-beta1 coregulate chondrocyte differentiation in vitro.

Authors:  E Nasatzky; E Azran; D D Dean; B D Boyan; Z Schwartz
Journal:  Endocrine       Date:  2000-12       Impact factor: 3.633

5.  Alteration of secretion of parathyroid hormone-related peptide and expression of its mRNA in a human hepatoma cell line (HEP G2) treated with agents that affect cell growth.

Authors:  H Li; P K Seitz; P Selvanayagam; S Rajaraman; C W Cooper
Journal:  Endocrine       Date:  1996-12       Impact factor: 3.633

6.  Feline head and neck squamous cell carcinoma cell line: characterization, production of parathyroid hormone-related protein, and regulation by transforming growth factor-beta.

Authors:  S Tannehill-Gregg; E Kergosien; T J Rosol
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001 Nov-Dec       Impact factor: 2.416

7.  Alternative splicing of parathyroid hormone-related protein mRNA: expression and stability.

Authors:  R S Sellers; A I Luchin; V Richard; R M Brena; D Lima; T J Rosol
Journal:  J Mol Endocrinol       Date:  2004-08       Impact factor: 5.098

8.  TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development.

Authors:  J J Yin; K Selander; J M Chirgwin; M Dallas; B G Grubbs; R Wieser; J Massagué; G R Mundy; T A Guise
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

9.  Parathyroid hormone-related protein and ezrin are up-regulated in human lung cancer bone metastases.

Authors:  Xiyun Deng; Sarah H Tannehill-Gregg; Murali V P Nadella; Guangchun He; Andrea Levine; Ya Cao; Thomas J Rosol
Journal:  Clin Exp Metastasis       Date:  2007-03-17       Impact factor: 4.510

10.  Parathyroid hormone-related protein secretion is inhibited by oestradiol and stimulated by antioestrogens in KPL-3C human breast cancer cells.

Authors:  J Kurebayashi; H Sonoo
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.